Published Date: 09/15/2023
Expiration Date: 09/15/2024
Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2023 conference for the frontline HIV care team, this module will examine best practices for evaluating people with HBV and HIV and will review the risk of liver complications associated with HBV viremia in people with HIV.
Jessie Torgersen, MD, MHS, MSCE, is a board-certified infectious disease physician in the Division of Infectious Diseases at the University of Pennsylvania Perelman School of Medicine. She is the Director of the Penn Center for Viral Hepatitis at Penn Presbyterian Medical Center where she provides care focused on acute and chronic liver diseases in people with HIV (PWH) and people without HIV (PWoH). She serves as an advisor to the City of Philadelphia’s efforts to improve viral hepatitis and HIV care for people with substance use disorder and serves as an advisor to the Hepatitis B Foundation’s Project ECHO initiative. Dr. Torgersen is a Senior Scholar in the Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania where her research focuses on the clinical epidemiology of chronic liver disease and HIV infection. She is an active investigator within the national Veterans Aging Cohort Study and the Penn Center for AIDS Research where her recent work has focused on viral hepatitis, hepatic steatosis, and hepatocellular carcinoma in PWH and PWoH.
